Investment portfolio
The Company continues to be
a generalist investor, with large
allocations in the soſtware, healthcare/
bio-technology and consumer sectors.
The older investments made under
the ‘pre 2015’ rules continue to be
realised, and comprised 19% by value
of the Company’s investments as of
the balance sheet date. This mature
portfolio will continue to reduce as a
percentage of overall capital invested
as we realise our holdings in these
investments, and we expect that it
will continue to provide a series of
profitable exits in the years to come,
supporting the overall return of the
Company.
Over the year the Company saw
reductions in the valuations of its listed
investments, notably the continued
fall in value of AIM listed musicMagpie
and the listed portfolio of investments,
in line with the decline in investment
markets generally. Overall, the value
of the Company’s listed investments
declined by £1.9 million of which
£1.0 million was MusicMagpie.
Despite
the marked-to-market losses of the
listed portfolio that is held to generate
a yield on cash pending investment,
the portfolio has generated annualised
total returns of 3.1% since investment
in 2018 and has therefore provided a
positive contribution to NAV in what
has been a very low interest rate
environment. Your Directors always
consider the state of the investment
markets and how these might impact
the valuations of the unquoted
venture portfolio and have updated
valuations to reflect current market
conditions where appropriate.
Investment levels have remained
high and exceeded the previous
year’s record breaking deployment
level, with £10.0 million of capital
provided to nine new venture capital
investments and £6.0 million of follow
on capital invested into 19 existing
portfolio investments, including a
second tranche of investment into
one company that was new in the
year (previous year: £14.7 million
combined).
Share offer and liquidity
As a result of the public share offer
launched in January 2023, 10,290,184
new ordinary shares were issued in
April 2023 for gross proceeds of £6.0
million.
Following the smaller non-prospectus
top-up offer in 2022/23, and taking
into account the increased rate
of investment that has now been
sustained for a second successive
year, the Board is pleased to
announce that the Company will
launch a prospectus offer in the
2023/24 tax year for £14.0 million,
with an over-allotment facility of
£6.0 million. This offer will launch in
September 2023, and full details will
be published shortly.
Our dividend investment scheme
continues to operate. This enables
shareholders to invest their dividends
in new ordinary shares free of dealing
costs and with the benefit of the
tax reliefs available on new VCT
share subscriptions. During the year
around 15% of total dividends were
reinvested by shareholders.
We have maintained our policy
of being willing to buy back the
Company’s shares in the market
when necessary in order to maintain
liquidity, at a 5% discount to
NAV. During the year, a total of
4,673,456 shares were repurchased
for cancellation, equivalent to
approximately 2.5% of the opening
share capital.
Changes to the performance-
related management fee
(‘performance fees’)
Following a review of current
arrangements by the Board,
included in the Circular for the
upcoming General Meeting is a
resolution proposing changes to
the Management Agreement in
relation to the performance-related
management fee with the Manager.
If approved by shareholders, these
changes will be implemented by a
deed of variation to the Company’s
existing Management Agreement.
The changes in VCT legislation in
2015 required the Company to
focus new investment on earlier
stage companies which, by their
nature, are higher risk and therefore
likely to deliver more volatile
investment returns. A number of
changes are proposed in order to
better align future performance
fees with shareholder returns as
well as to bring the performance
fee methodology more in line with
other market participants and to
harmonise its application across
the Northern VCTs. The changes
are designed to ensure strong
returns above a hurdle are delivered
consistently, not just in a single year,
with a requirement that any decline
in shareholder NAV must be made
wholly good before a performance
fee is payable to the Manager. Full
details of the changes are set out in
the accompanying Circular for the
general meeting, which will be held
immediately aſter the Annual General
Meeting on 29 July 2023
Responsible Investment
The Company is mindful of
its Environmental, Social and
Governance (ESG) responsibilities
and we have outlined our evolving
approach on pages 34 to 39.
VCT legislation and
qualifying status
The Company has continued to meet
the stringent and complex qualifying
conditions laid down by HM Revenue
& Customs for maintaining its
approval as a VCT. The Manager
monitors the position closely and
reports regularly to the Board.
Philip
Hare & Associates LLP has continued
to act as independent adviser to the
Company on VCT taxation matters.
The upcoming 2025 ‘sunset
clause’ was a European state aid
requirement when the VCT scheme
received state aid approval, which
means that without a change in
legislation investors will not receive
upfront tax relief when investing in
VCTs from 6 April 2025. While the
government has signalled that it will
extend the scheme, to date no formal
legislation has been introduced
to enact this commitment. The
Company and the Manager will
continue to monitor progress in this
area. The Board considers that the
Company, and VCTs more generally,
are successfully delivering against
the Government’s mandate, which
is to channel money into higher-risk,
early-stage businesses.
Another issue facing VCTs and similar
schemes such as the Enterprise
Investment Scheme is the ‘Financial
Health Test’ that has been enforced
more narrowly over the past twelve
months. This test states that where
a company is investing outside
of its initial investing period, if
more than half of an investee
company’s subscribed share capital
has disappeared as a result of
accumulated losses, then no further
capital may be invested. In reality
a number of early stage businesses
need to be funded for longer than
that initial period, making losses
originally to fund growth. The
Manager has performed a detailed
review of the portfolio, and while
the Company’s portfolio is relatively
unaffected at the current time, your
Board will continue to monitor the
situation carefully.
Whilst no further amendments to
the VCT legislation were announced
by the Chancellor in his 2023 Budget
statement, it is possible that further
changes will be made in the future.
We will continue to work closely with
the Manager to maintain compliance
with the scheme rules at all times.
Northern 2 VCT PLC
Annual Report and Financial Statements
09
02